Literature DB >> 33895815

Mutation rates and selection on synonymous mutations in SARS-CoV-2.

Nicola De Maio1, Conor R Walker1,2, Yatish Turakhia3,4, Robert Lanfear5, Russell Corbett-Detig3,4, Nick Goldman1.   

Abstract

The COVID-19 pandemic has seen an unprecedented response from the sequencing community. Leveraging the sequence data from more than 140,000 SARS-CoV-2 genomes, we study mutation rates and selective pressures affecting the virus. Understanding the processes and effects of mutation and selection has profound implications for the study of viral evolution, for vaccine design, and for the tracking of viral spread. We highlight and address some common genome sequence analysis pitfalls that can lead to inaccurate inference of mutation rates and selection, such as ignoring skews in the genetic code, not accounting for recurrent mutations, and assuming evolutionary equilibrium. We find that two particular mutation rates, G →U and C →U, are similarly elevated and considerably higher than all other mutation rates, causing the majority of mutations in the SARS-CoV-2 genome, and are possibly the result of APOBEC and ROS activity. These mutations also tend to occur many times at the same genome positions along the global SARS-CoV-2 phylogeny (i.e., they are very homoplasic). We observe an effect of genomic context on mutation rates, but the effect of the context is overall limited. While previous studies have suggested selection acting to decrease U content at synonymous sites, we bring forward evidence suggesting the opposite.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.

Entities:  

Keywords:  COVID-19; Mutation; SARS-CoV-2; Selection; Sequencing; Viral genomics

Year:  2021        PMID: 33895815     DOI: 10.1093/gbe/evab087

Source DB:  PubMed          Journal:  Genome Biol Evol        ISSN: 1759-6653            Impact factor:   3.416


  26 in total

1.  Genome-wide identification and prediction of SARS-CoV-2 mutations show an abundance of variants: Integrated study of bioinformatics and deep neural learning.

Authors:  Md Shahadat Hossain; A Q M Sala Uddin Pathan; Md Nur Islam; Mahafujul Islam Quadery Tonmoy; Mahmudul Islam Rakib; Md Adnan Munim; Otun Saha; Atqiya Fariha; Hasan Al Reza; Maitreyee Roy; Newaz Mohammed Bahadur; Md Mizanur Rahaman
Journal:  Inform Med Unlocked       Date:  2021-11-18

2.  Insertion-and-Deletion Mutations between the Genomes of SARS-CoV, SARS-CoV-2, and Bat Coronavirus RaTG13.

Authors:  Tetsuya Akaishi
Journal:  Microbiol Spectr       Date:  2022-06-06

3.  Continent-wide evolutionary trends of emerging SARS-CoV-2 variants: dynamic profiles from Alpha to Omicron.

Authors:  Chiranjib Chakraborty; Manojit Bhattacharya; Ashish Ranjan Sharma; Kuldeep Dhama; Sang-Soo Lee
Journal:  Geroscience       Date:  2022-07-13       Impact factor: 7.581

4.  Host-specific asymmetric accumulation of mutation types reveals that the origin of SARS-CoV-2 is consistent with a natural process.

Authors:  Ke-Jia Shan; Changshuo Wei; Yu Wang; Qing Huan; Wenfeng Qian
Journal:  Innovation (Camb)       Date:  2021-08-30

Review 5.  Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.

Authors:  Daniele Focosi; Fabrizio Maggi
Journal:  Rev Med Virol       Date:  2021-03-16       Impact factor: 11.043

6.  The substitution spectra of coronavirus genomes.

Authors:  Diego Forni; Rachele Cagliani; Chiara Pontremoli; Mario Clerici; Manuela Sironi
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

7.  A Bacterial Cell-Based Assay To Study SARS-CoV-2 Protein-Protein Interactions.

Authors:  Benjamin L Springstein; Padraig Deighan; Grzegorz J Grabe; Ann Hochschild
Journal:  mBio       Date:  2021-11-16       Impact factor: 7.867

Review 8.  The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies.

Authors:  Shilei Zhang; Lulan Wang; Genhong Cheng
Journal:  Mol Ther       Date:  2022-02-14       Impact factor: 12.910

9.  Differences in Clinical Characteristics Between Delta Variant and Wild-Type SARS-CoV-2 Infected Patients.

Authors:  Zhenkui Hu; Xing Huang; Jianguo Zhang; Shixiang Fu; Daoyin Ding; Zhimin Tao
Journal:  Front Med (Lausanne)       Date:  2022-01-03

10.  Evidence for a mouse origin of the SARS-CoV-2 Omicron variant.

Authors:  Changshuo Wei; Ke-Jia Shan; Weiguang Wang; Shuya Zhang; Qing Huan; Wenfeng Qian
Journal:  J Genet Genomics       Date:  2021-12-24       Impact factor: 4.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.